Diabetes Res Clin Pract. 2011; 93(2): e87-e91

Response at 3 months to insulin dose decisions made at exenatide initiation in the Association of British Clinical Diabetologists (ABCD) nationwide exenatide audit

K.Y. Thong ^a,1, B. Jose ^a,1, A.D. Blann ^a,1, M.L. Cull ^a,1, A.P. Mills^a,1 , T. Sathyapalan^b,1 , C. Walton^b,1 , R.E.J. Ryder^a,1 On behalf of the ABCD nationwide exenatide contributors^†

^aCity Hospital, Birmingham, United Kingdom

^bHull Royal Infirmary, Hull, United Kingdom

^†List of ABCD nationwide exenatide contributors (see Appendix A)